GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Bodisen Biotech Inc (FRA:DZ9) » Definitions » Cyclically Adjusted Revenue per Share

Bodisen Biotech (FRA:DZ9) Cyclically Adjusted Revenue per Share : €0.00 (As of Jun. 2013)


View and export this data going back to . Start your Free Trial

What is Bodisen Biotech Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Bodisen Biotech's adjusted revenue per share for the three months ended in Jun. 2013 was €0.024. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €0.00 for the trailing ten years ended in Jun. 2013.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-06-23), Bodisen Biotech's current stock price is €0.53. Bodisen Biotech's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2013 was €0.00. Bodisen Biotech's Cyclically Adjusted PS Ratio of today is .


Bodisen Biotech Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Bodisen Biotech's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bodisen Biotech Cyclically Adjusted Revenue per Share Chart

Bodisen Biotech Annual Data
Trend Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Bodisen Biotech Quarterly Data
Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Jun13
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Bodisen Biotech's Cyclically Adjusted Revenue per Share

For the Agricultural Inputs subindustry, Bodisen Biotech's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bodisen Biotech's Cyclically Adjusted PS Ratio Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Bodisen Biotech's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bodisen Biotech's Cyclically Adjusted PS Ratio falls into.



Bodisen Biotech Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bodisen Biotech's adjusted Revenue per Share data for the three months ended in Jun. 2013 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2013 (Change)*Current CPI (Jun. 2013)
=0.024/95.9841*95.9841
=0.024

Current CPI (Jun. 2013) = 95.9841.

Bodisen Biotech Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
200306 0.234 70.039 0.321
200309 0.245 71.018 0.331
200312 -0.433 72.808 -0.571
200403 0.117 73.682 0.152
200406 0.228 73.459 0.298
200409 0.289 74.637 0.372
200412 0.213 74.488 0.274
200503 0.230 75.597 0.292
200506 0.441 74.618 0.567
200509 0.550 75.290 0.701
200512 0.391 75.666 0.496
200603 0.504 76.340 0.634
200606 0.707 76.034 0.893
200609 0.546 76.413 0.686
200612 0.165 77.793 0.204
200703 0.206 78.884 0.251
200706 0.129 79.357 0.156
200709 0.091 81.276 0.107
200712 0.061 82.911 0.071
200803 0.032 85.485 0.036
200806 0.041 85.058 0.046
200809 0.064 85.057 0.072
200812 0.150 83.956 0.171
200903 0.063 84.457 0.072
200906 0.041 83.615 0.047
200909 0.017 84.369 0.019
200912 0.047 85.386 0.053
201003 0.041 86.316 0.046
201006 0.127 85.886 0.142
201009 0.090 87.267 0.099
201012 0.037 89.289 0.040
201103 0.034 91.154 0.036
201106 0.046 91.612 0.048
201109 0.060 92.711 0.062
201112 0.122 92.885 0.126
201203 0.038 94.367 0.039
201206 0.054 93.495 0.055
201209 0.120 94.482 0.122
201212 0.079 95.237 0.080
201306 0.024 95.984 0.024

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Bodisen Biotech  (FRA:DZ9) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Bodisen Biotech Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Bodisen Biotech's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Bodisen Biotech (FRA:DZ9) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Bodisen Biotech Inc develops, manufactures and sells organic fertilizers, liquid fertilizers, pesticides and insecticides in China.

Bodisen Biotech (FRA:DZ9) Headlines

No Headlines